Drug Target Review2025-07-29T14:00:59
Effective financial management is vital for clinical trial success, yet many preclinical and clinical companies face inefficiencies due to outdated systems. Jennifer Kyle, CEO of Condor Software, explains how advanced financial platforms can streamline processes, improve forecasting and ensure better resource allocation throughout drug development.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2026-07-23T06:20:00
Contributor Laura Lotfi, Drug Target Review
2023-03-30T09:15:30
Sponsored by Halo Labs
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-01-06T16:37:30
Sponsored by Catalent
Site powered by Webvision Cloud